Observia
Guillaume HUBERT has a diverse work experience in the healthcare industry. Guillaume began their career at Bristol-Myers Squibb, where they worked as an Assistant chef de Projet from 2007 to 2008. Guillaume then joined Alcimed in 2009, starting as a Consultant Healthcare and later becoming a Project Manager. In 2013, they were promoted to Business Unit Director, Healthcare, a position they held until 2015. Since 2015, Guillaume has been working at Observia, first as Directeur des Opérations and currently as Managing Director EMEA.
From 2005 to 2008, Guillaume HUBERT attended AgroParisTech, where they obtained a degree in Ingénieur AgroParisTech with a focus on Gestion, Innovation et Performance des Entreprises.
This person is not in any offices
Observia
Since 2011, we have been a passionate pioneering health tech company committed to driving the healthcare (r)evolution and improving patients’ lives. We work with healthcare stakeholders that aim to create value at every step of the patient journey: industrial companies, healthcare facilities, healthcare professionals, and patient organizations. As a European reference, we help companies to develop personalized, intelligent patient engagement and support solutions, and to define and implement patient strategies. We have created a new generation of evidence-based tools to support efficient patient behavioral change and improve the user experience. d.tells™, our smart engine for personalizing patient solutions, is powered by SPUR™, our behavioral diagnostic tool, and OPC™, our digital cloud platform that supports client’s developments. Our products are anchored in the behavioral sciences and driven by artificial intelligence, two critical pillars that promote effective personalization. These tools successfully help patients to overcome behavioral challenges, such as treatment non-adherence, and deliver clinically measurable results. Observia has been created in 2011 by three founders. After 3 years in Paris Biotech Santé incubator in Cochin hospital, Observia settled in Paris and opened a subsidiary in Shanghai in 2018. In 2021, the company employs more than 50 people and does 60% of its turnover internationally.